Hépatitis B jeung kanker ati
Di Afrika, hépatitis B mangrupikeun panyabab utama kanker ati, nyababkeun 80% kasus kanker ati. Henteu aya pangobatan atanapi ubar khusus pikeun hépatitis B akut, sareng sabagéan ageung sawawa maju ka panyakit kronis. Diagnosis hépatitis B kronis nyaéta lulus tés spidol getih tangtu anu lepas 6 bulan atawa leuwih sanggeus inféksi awal. Sanajan vaksinasi bisa nyegah inféksi hépatitis B, sababaraha barudak geus kainfeksi hepatitis B ti lahir atawa kirang ti lima taun. Inféksi kronis dicirikeun ku nyeri beuteung, panon konéng, cikiih poék, atawa tés ati abnormal, tapi dina sababaraha kasus meureun aya euweuh gejala.
The main problem with chronic hepatitis B is the risk of developing cirrhosis and / or kanker haté. For those with chronic infections, taking medicine once a day can prevent the virus from multiplying. When the virus stops growing, the risk of liver cirrhosis and liver cancer is reduced. Hepatitis B can be prevented by vaccination and has been included as part of the Kenya Expanded Immunization Program (KEPI). Newborns need to be vaccinated at 6 weeks, 10 weeks and 14 weeks.
Vaksinasi sawawa réngsé tilu suntikan dina genep bulan. Upami tes getih nunjukkeun yén kekebalan ka hépatitis B henteu dina tingkat anu diperyogikeun, dosis booster diperyogikeun. Pikeun pasien anu nampi dosis pinuh, vaksin sacara efektif tiasa nyegah inféksi hépatitis, tingkat efektifna 80% dugi ka 100%.
https://www.nation.co.ke/health/Fight-hepatitis-B-to-prevent-liver-cirrhosis-and-cancer/3476990-4763768-v0ltkh/index.html
